Oligomerix

Developer of therapeutics for Alzheimer’s disease and related neurodegenerative diseases

placeNew York City, New York, United States calendar_todayFounded 2006 groups11 employees language oligomerix.com

Innovation

12 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities, Physics & computing; filing pace slowing. Cited 623 times.

YearFilings
20141
20151
20163
20173
20182
20194
20203
20214
20222
20231
20244
20251

Social engagement

Social engagement: 1.2K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

6 investors on record.

Investor typeCountShare
Venture capital117%
Private equity117%
Other / undisclosed467%
Coming soon